Transarterial chemoembolization refractoriness in hepatocellular carcinoma: Chinese College of Interventionalists definition and consensus statement-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transarterial chemoembolization refractoriness in hepatocellular carcinoma: Chinese College of Interventionalists definition and consensus statement

Published:2024-08-02 Issue:17 Volume:137 Page:2040-2042
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Zhong Binyan¹,Zhang Shen¹,Zhu Haidong²,Wang Wansheng¹,Ni Caifang¹,

Affiliation:

1. Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China

2. Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu 210009, China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference8 articles.

1. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update;Reig;J Hepatol,2022

2. Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma;Zhong;J Clin Transl Hepatol,2023

3. Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition);Zhou;Liver Cancer,2020

4. Transarterial chemoembolization failure/refractoriness: JSH-LCSGJ criteria 2014 update;Kudo;Oncology,2014

5. Clinical practice of transarterial chemoembolization for hepatocellular carcinoma: consensus statement from an international expert panel of International Society of Multidisciplinary Interventional Oncology (ISMIO);Lu;Hepatobiliary Surg Nutr,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP